Impact of GLP-1 Receptor Agonists on Brain Health and Addictive Behaviours
AI-Generated Summary
A recent study reveals GLP-1 receptor agonists like Ozempic and Mounjaro show benefits in brain health and addiction management among diabetic US veterans, while highlighting both risks and therapeutic potential.
One of the world's largest studies of Ozempic, Mounjaro, and other notable diabetes and obesity drugs has highlighted their significant impact on the brain, indicating benefits related to addiction and schizophrenia.
